SCHEMBL7956699

SCHEMBL7956699

c1ccc(COc2ccc(OC3CCN(c4ccncc4)C3)nc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACACB O00763 11/20 0.48
F10 P00742 4/20 0.46
ACACA Q13085 1/20 0.42
MCHR1 Q99705 1/20 0.42
OXTR P30559 1/20 0.41
AVPR1A P37288 1/20 0.41
FFAR4 Q5NUL3 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7956714 0.88 ACACB (0.60) ACACBF10MCHR1FFAR4
SCHEMBL7954806 0.81 ACACB (0.38) ACACBF10OXTRAVPR1AFFAR4
SCHEMBL7961303 0.81 F10 (0.54) ACACBF10MCHR1FFAR4
SCHEMBL7957015 0.77 ACACB (0.41) ACACBOXTRAVPR1A
SCHEMBL7947301 0.77 ACACB (0.41) ACACBOXTRAVPR1A
SCHEMBL5632542 0.77 ACACB (0.43) ACACBOXTRAVPR1A
SCHEMBL7961553 0.77 ACACB (0.41) ACACBOXTRAVPR1A
SCHEMBL7954744 0.77 FPR2 (0.43) ACACBF10
SCHEMBL7955313 0.74 ACACB (0.49) ACACBFFAR4
SCHEMBL7956252 0.74 LIPG (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed